Hestia Insight Inc. Signs Letter of Intent With Le
Post# of 6
(Total Views: 125)
Posted On: 05/18/2023 2:37:37 PM
Hestia Insight Inc. Signs Letter of Intent With Leading Wound Care Company
NEW YORK, NY, May 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Hestia Insight Inc. (OTCQB: HSTA) (“Hestia Insight” and the “Company”), a company focused on the development and operation of novel technologies in the healthcare and biotech sectors, as well as providing sales and marketing guidance and capital markets advisory services to its clients, today announced that it has entered into a Letter of Intent with RecentCare Biomedical, Inc., Taipei, Taiwan, (“RecentCare Biomedical”), a leading Wound Care company, beginning the potential M&A transaction due diligence process.
Hestia Insight has been active in searching for attractive potential acquisition targets in the healthcare sector with the goal of strengthening the Company’s business model and adding to its revenue, intellectual property, and global presence.
RecentCare Biomedical, established in 2013 in Taiwan, are leading experts at providing successful solutions for wound care. RecentCare Biomedical maintains an outstanding research & development team and possesses a complete ISO 13485 manufacturing process meeting global requirements. Its core technology has acquired multiple patent certifications and the company uses its hydrogel techniques in various fields, including medical, and skin care and drug delivery.
Edward Lee, CEO of Hestia Insight, stated, “RecentCare Biomedical addresses a multi-billion-dollar world market, in which it can bring outstanding products to cure and comfort people worldwide. We are thrilled to have the opportunity to combine this exceptional company with the Hestia Insight family so that we may grow together to achieve a strong and prosperous organization.”
Mr. Lee continued, “We will continue to work diligently to refine our business model and seek to identify strong international companies primarily focused on the healthcare industry consistent with our mission to help people become healthier and to build a better world.”
For more information about Hestia Insight, please visit the Company’s website: www.hestiainsight.com
Hestia Insight Investor Relations: investors.hestiainsight.com
Facebook: Hestia Insight Inc.
LinkedIn: Hestia Insight Inc.
Twitter: @HestiaInsight
Investor Relations Contact:
Paul Knopick
Tel: 940.262.3584
Email: pknopick@eandecommunications.com
NEW YORK, NY, May 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Hestia Insight Inc. (OTCQB: HSTA) (“Hestia Insight” and the “Company”), a company focused on the development and operation of novel technologies in the healthcare and biotech sectors, as well as providing sales and marketing guidance and capital markets advisory services to its clients, today announced that it has entered into a Letter of Intent with RecentCare Biomedical, Inc., Taipei, Taiwan, (“RecentCare Biomedical”), a leading Wound Care company, beginning the potential M&A transaction due diligence process.
Hestia Insight has been active in searching for attractive potential acquisition targets in the healthcare sector with the goal of strengthening the Company’s business model and adding to its revenue, intellectual property, and global presence.
RecentCare Biomedical, established in 2013 in Taiwan, are leading experts at providing successful solutions for wound care. RecentCare Biomedical maintains an outstanding research & development team and possesses a complete ISO 13485 manufacturing process meeting global requirements. Its core technology has acquired multiple patent certifications and the company uses its hydrogel techniques in various fields, including medical, and skin care and drug delivery.
Edward Lee, CEO of Hestia Insight, stated, “RecentCare Biomedical addresses a multi-billion-dollar world market, in which it can bring outstanding products to cure and comfort people worldwide. We are thrilled to have the opportunity to combine this exceptional company with the Hestia Insight family so that we may grow together to achieve a strong and prosperous organization.”
Mr. Lee continued, “We will continue to work diligently to refine our business model and seek to identify strong international companies primarily focused on the healthcare industry consistent with our mission to help people become healthier and to build a better world.”
For more information about Hestia Insight, please visit the Company’s website: www.hestiainsight.com
Hestia Insight Investor Relations: investors.hestiainsight.com
Facebook: Hestia Insight Inc.
LinkedIn: Hestia Insight Inc.
Twitter: @HestiaInsight
Investor Relations Contact:
Paul Knopick
Tel: 940.262.3584
Email: pknopick@eandecommunications.com
(0)
(0)Hestia Insight Inc. (HSTA) Stock Research Links
Scroll down for more posts ▼